Zacks Investment Research upgraded shares of ANALOGIC CORP (ALOG) from UNDERPERFORM to NEUTRAL on August 15, 2012, with a target price of $65.10.
Analogic Corporation conceives, designs, manufactures, and sells standard and customized high-precision data acquisition, signal and imaging processing based medical imaging and industrial systems and subsystems. Analogic's principal customers are original equipment manufacturers who incorporate Analogic's state-of-the-art products into systems used in medical, industrial and scientific applications.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on ANALOGIC CORP (ALOG),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment